According to Rick MIlls who's blog "AheadoftheHerd" is often, exactly that, tiny Sernova Corp is on the verge of something very big in the search for a "safe and compatible device for housing therapeutic cells in human’s".
It appears that, in the "gold rush" to deliver cutting edge therapies directly the the cells of humans, Sernova will own the "picks and shovels" of that gold rush.
As Rick points out in his well researched report, Sernova's innovative "Cell Pouch™ could be used for any chronic disease where a deficient or missing protein or hormone can be replaced by therapeutic cell transplantation."
Sernova has been developing it's cutting edge technology for many years, and only now has it been independently verified as being a proven method of delivering new cutting edge stem cell therapy for a number of critical diseases including (but not limited to) Diabetes and Hemophilia.
Many other companies, small and large, are researching and perfecting these types of stem cell therapies, Sernova has focused on the actual delivery mechanism which should benefit "all" of those other companies coming to market with new medicines and therapies.
After all, it was the suppliers of the "picks and shovels, and horses and supplies who made the most money during the great Klondike Gold rush. It appears that lesson was not lost on the founders of Sernova Corp.
Here is Ricks excellent summary on this rising penny stock..